DossierENTITY

Lausanne

Coverage of Lausanne in the Nexus archive.

Earliest in view: Jul 17 · 18:10 UTCMost recent: Jul 17 · 18:10 UTC

Co-mentioned in this coverage

MindMaze Therapeuticsorganization1 Zach Hendersonperson1 Connect Labs by Wexfordorganization1 The Pearl innovation districtplace1 Charlotteplace1 neurotherapeutic technologytopic1 stroketopic1 Alzheimer diseasetopic1 Parkinson diseasetopic1

Recent coverage

BUSINESSJul 17 · 18:10 UTCWSOC ABC CHARLOTTE
$1B Swiss biotech establishes US headquarters in the Queen City
Swiss biotech company MindMaze Therapeutics has established its U.S. headquarters in Charlotte's The Pearl innovation district. The company, which focuses on neurotherapeutic technology for stroke, Alzheimer disease, and Parkinson disease, opened a Patient Experience Center in May at Connect Labs by Wexford.

Lausanne · Dossier · The Nexus